| ARDS | Acute respiratory distress syndrome |
| c-di-AMP | Bis-(3′,5′)-cyclic diadenosine monophosphate |
| c-di-GMP | Bis-(3′,5′)-cyclic diguanosine monophosphate |
| CDN | Cyclic dinucleotide |
| CF | Cystic fibrosis |
| cGAMP | 2′3′-cyclic GMP-AMP |
| COPA | Coatomer protein subunit alpha |
| COPD | Chronic obstructive pulmonary disease |
| CRSwNP | Chronic rhinosinusitis with nasal polyps |
| CTT | C-terminal tail |
| DDR | DNA damage response |
| ER | Endoplasmic reticulum |
| ERGIC | ER-Golgi intermediate compartment |
| GMWCNT | graphitized multi-walled carbon nanotubes |
| HDM | House dust mite |
| IDO | Indoleamine 2,3 dioxygenase |
| IFN | Interferon |
| ILC2 | Type 2 innate lymphoid cells |
| ILD | Interstitial lung disease |
| IPF | Idiopathic pulmonary fibrosis |
| IRF3 | Interferon regulatory factor 3 |
| ISG | Interferon-stimulated gene |
| JAK | Janus kinase |
| LLC | Lewis lung carcinoma |
| MAVS | Mitochondrial antiviral-signaling protein |
| NF-κB | Nuclear factor κB |
| NO2-Fas | Nitro-fatty acids |
| NSCLC | Non-small cell lung cancer |
| NTHI | Nontypeable Haemophilus influenzae |
| OVA | Ovalbumin |
| PARP | Poly(ADP-ribose) polymerase |
| PD-1 | Programmed death-1 |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus-2 |
| SAVI | STING-associated vasculopathy with onset in infancy |
| SCID | severe combined immunodeficiency disease |
| SCLC | Small cell lung carcinoma |
| STAT | Signal transducer and activator of transcription |
| TBK1 | TANK-binding kinase 1 |